Volume 24, Issue 3, Pages (November 1999)

Slides:



Advertisements
Similar presentations
Specific and Innervation-Regulated Expression of the Intermediate Filament Protein Nestin at Neuromuscular and Myotendinous Junctions in Skeletal Muscle 
Advertisements

Biphasic Alteration of the Inhibitory Synapse Scaffold Protein Gephyrin in Early and Late Stages of an Alzheimer Disease Model  Eva Kiss, Karin Gorgas,
Figure 2. Macrophages in dystrophic muscle in vivo and in vitro express Klotho. (A) A cross-section of 4-week-old mdx muscle labeled with antibodies to.
Volume 18, Issue 3, Pages (September 2013)
Volume 35, Issue 1, Pages (July 2002)
Volume 18, Issue 4, Pages (April 1997)
Defective Neuromuscular Synaptogenesis in Agrin-Deficient Mutant Mice
Pericentrosomal Localization of the TIG3 Tumor Suppressor Requires an N-Terminal Hydrophilic Region Motif  Tiffany M. Scharadin, Gautam Adhikary, Kristin.
Skin-Specific Expression of ank-393, a Novel Ankyrin-3 Splice Variant
VEGF Gene Delivery to Muscle
Schwann cells: Dynamic roles at the neuromuscular junction
Volume 24, Issue 3, Pages (November 1999)
Volume 131, Issue 5, Pages (November 2007)
Critical Role of Complement and Viral Evasion of Complement in Acute, Persistent, and Latent γ-Herpesvirus Infection  Sharookh B. Kapadia, Beth Levine,
Volume 127, Issue 1, Pages (July 2004)
Volume 46, Issue 4, Pages (May 2005)
Volume 19, Issue 4, Pages (October 1997)
Activation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by AAV Gene Transfer Protects Retinal Ganglion Cells in Glaucoma  Yu Zhou, Vincent.
Knockdown of Myosin Va Isoforms by RNAi as a Tool to Block Melanosome Transport in Primary Human Melanocytes  Mireille Van Gele, Barbara Geusens, Anne-Marie.
Volume 10, Issue 18, Pages (September 2000)
Volume 2, Issue 5, Pages (November 2000)
Volume 111, Issue 3, Pages (November 2002)
Colocalization of Kindlin-1, Kindlin-2, and Migfilin at Keratinocyte Focal Adhesion and Relevance to the Pathophysiology of Kindler Syndrome  J.E. Lai-Cheong,
Marie-Thérèse Leccia  Journal of Investigative Dermatology 
Katerina Akassoglou, Wei-Ming Yu, Pinar Akpinar, Sidney Strickland 
Volume 21, Issue 2, Pages (August 1998)
Volume 90, Issue 8, Pages (April 2006)
Volume 120, Issue 3, Pages (February 2005)
Volume 16, Issue 12, Pages (June 2006)
Volume 14, Issue 1, Pages (January 2004)
Volume 2, Issue 3, Pages (March 2014)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 22, Issue 20, Pages (October 2012)
Volume 110, Issue 6, Pages (September 2002)
Volume 8, Issue 2, Pages (February 2017)
Volume 19, Issue 2, Pages (August 1997)
Volume 124, Issue 7, Pages (June 2003)
Volume 24, Issue 1, Pages (September 1999)
Volume 50, Issue 3, Pages (May 2006)
Volume 37, Issue 6, Pages (March 2003)
Synaptic Innervation Density Is Regulated by Neuron-Derived BDNF
Volume 55, Issue 5, Pages (September 2007)
Volume 18, Issue 5, Pages (May 1997)
Kentaro Abe, Masatoshi Takeichi  Neuron 
Impaired TrkB signaling in the cerebellum of Pex14ΔC/ΔC BL/ICR mice.
Volume 25, Issue 8, Pages (August 2017)
Volume 103, Issue 6, Pages (December 2000)
Volume 32, Issue 3, Pages (November 2001)
Ashkan Javaherian, Hollis T. Cline  Neuron 
Volume 28, Issue 1, Pages (October 2000)
Ubiquitin-Related Proteins Regulate Interaction of Vimentin Intermediate Filaments with the Plasma Membrane  Ai-Ling Wu, Jun Wang, Alexander Zheleznyak,
EphB/Syndecan-2 Signaling in Dendritic Spine Morphogenesis
Expression of Activated MEK1 in Differentiating Epidermal Cells Is Sufficient to Generate Hyperproliferative and Inflammatory Skin Lesions  Robin M. Hobbs,
Volume 112, Issue 2, Pages (January 2003)
Volume 129, Issue 2, Pages (April 2007)
Taeyoon Kim, Jung-Hwa Tao-Cheng, Lee E. Eiden, Y.Peng Loh  Cell 
Toshiyuki Araki, Jeffrey Milbrandt  Neuron 
In Vivo Time-Lapse Imaging of Synaptic Takeover Associated with Naturally Occurring Synapse Elimination  Mark K. Walsh, Jeff W. Lichtman  Neuron  Volume.
Volume 6, Issue 3, Pages (September 2002)
Volume 98, Issue 3, Pages (August 1999)
Alternatively Spliced Isoforms of Nerve- and Muscle-Derived Agrin
Volume 49, Issue 4, Pages (February 2006)
Volume 22, Issue 19, Pages (October 2012)
Volume 18, Issue 5, Pages (May 1997)
Destabilization of Cortical Dendrites and Spines by BDNF
Volume 16, Issue 4, Pages (April 1996)
Alzheimer Presenilins in the Nuclear Membrane, Interphase Kinetochores, and Centrosomes Suggest a Role in Chromosome Segregation  Jinhe Li, Min Xu, Hui.
IR expression in the olfactory epithelium.
Volume 20, Issue 3, Pages (March 1998)
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Presentation transcript:

Volume 24, Issue 3, Pages 567-583 (November 1999) Disruption of TrkB-Mediated Signaling Induces Disassembly of Postsynaptic Receptor Clusters at Neuromuscular Junctions  Michael Gonzalez, Francis P Ruggiero, Qiang Chang, Yi-Jun Shi, Mark M Rich, Susan Kraner, Rita J Balice-Gordon  Neuron  Volume 24, Issue 3, Pages 567-583 (November 1999) DOI: 10.1016/S0896-6273(00)81113-7

Figure 1 TrkB Expression at Adult and Neonatal Mouse Neuromuscular Junctions TrkB immunoreactivity (left), RαBTX staining of postsynaptic AChRs (middle), and an overlay (right; TrkB, green; AChRs, red) of neuromuscular junctions from adult innervated (A, C, and G) and denervated (B, D, and H) and neonatal P8 innervated (E) and denervated (F) mouse sternomastoid muscle. (A and B) Anti-trkB.FL immunoreactivity at innervated (A) and denervated (B) neuromuscular junctions is colocalized with AChR-rich areas. Faint immunoreactivity is also present in preterminal axons (asterisk). (C and D) Anti-trkB.t1 immunoreactivity at innervated (C) and denervated (D) neuromuscular junctions is interdigitated among AChR-rich areas; some faint immunoreactivity is colocalized with AChRs. (E–H) Immunoreactivity at innervated (E) and denervated (F) P8 and innervated (G) and denervated (H) adult neuromuscular junctions, revealed with an anti-TrkB antibody that recognizes both trkB.FL and trkB.t1, is localized within and surrounding AChR-rich regions. Inset in (G) shows the motor nerve terminal and axon immunostaining used to demonstrate that junctions were innervated. Inset in (H) shows the absence of this staining, which was used to determine that junctions were denervated. Scale bar, 20 μm. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 2 Specificity of Anti-Trk Antibodies and RT-PCR Amplification of TrkB.FL mRNA from Mouse Myotubes (A–C) Western blot of membrane protein preparations from brain and skeletal muscle probed with a rabbit polyclonal anti-trkB.FL-specific antibody that revealed a single ∼140 kDa band (A); a rabbit polyclonal anti-trkB.t1-specific antibody that revealed a single ∼95 kDa band (B); or a rabbit polyclonal anti-TrkB antibody that recognizes both trkB.FL and trkB.t1 which revealed two bands, of ∼140 kDa and ∼95 kDa (C). This antibody detected less trkB.FL than trkB.t1 in muscle. (D) RT-PCR amplification of trkB.FL mRNA from brain and mouse primary myotubes using nested primers resulted in detection of a 740 base pair band from brain and primary myotube cDNA, as expected, but not from water or myotube RNA negative control lanes. (E) Western blot of brain and skeletal muscle membrane protein preparations probed with a rabbit polyclonal anti-TrkA-specific antibody revealed a single ∼140 kDa band from brain but not muscle. (F) Confirming previous results (Klein et al. 1993), Western blot of brain membrane preparations from trkB+/− mice shows about half as much trkB.FL and somewhat less trkB.t1 expression compared with trkB+/+ mice. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 3 Adenovirus Constructs and Analysis of Transgene Expression (A) Plasmids containing a trkB.t1ha, t-trkAha, or LacZ cDNA, an IRES sequence, and GFP were transfected into 293 cells with a plasmid containing the adenovirus genome (dl327). After homologous recombination, screening, and plaque purification, high-titer adenovirus was generated. (B) Western blot analysis of transgene expression after infection of 293 cells with AdtrkB.t1ha-gfp (anti-trkB.t1, anti-HA, anti-GFP), Adt-trkAha-gfp (anti-TrkA, anti-HA, anti-GFP), or AdlacZ-gfp (anti-β-gal, anti-GFP) compared with expression after transfection with the plasmid used to generate adenovirus and endogenous trkB.t1 and TrkA from mouse brain. In AdtrkB.t1ha-gfp-infected cells, a band is detected at ∼95 kDa, the appropriate molecular mass for trkB.t1 (Klein et al. 1990), using anti-trkB.t1 and anti-HA antibodies; markers indicated by black lines are 116 and 83 kDa. Anti-GFP staining revealed a band at ∼24 kDa, similar to purified recombinant GFP (last lane); markers, 46 and 30 kDa. Anti-β-gal staining revealed a band at ∼116 kDa, similar to purified recombinant β-gal (last lane); markers, 116, 80, and 49.5 kDa. In Adt-trkAha-gfp-infected cells, a band is detected at ∼95 kDa, the predicted molecular mass generated by the hybrid, truncated TrkA construct, using anti-TrkA and anti-HA antibodies, and a ∼140 kDa band is detected in brain, the appropriate molecular mass for full-length TrkA; markers, 116 and 83 kDa. Anti-GFP staining revealed a band at ∼24 kDa, similar to purified recombinant GFP (last lane); markers, 46 and 30 kDa. (C) Gfp fluorescence and immunostaining of AdtrkB.t1ha-gfp- or Adt-trkAha-gfp-infected myotubes. Anti-HA immunoreactivity is localized in the membrane of GFP+ but not in GFP− myotubes infected with recombinant adenovirus. Anti-trkB.t1 immunoreactivity is colocalized with anti-HA immunoreactivity in the membrane of GFP+ myotubes; weak trkB.t1 immunoreactivity is also present in uninfected myotubes, consistent with the localization of trkB.t1 in the postsynaptic membrane of neonatal and adult muscle fibers (Figure 1). Anti-TrkA staining shows t-trkA is colocalized with anti-HA immunoreactivity in the cell membrane of GFP+ but not in GFP− myotubes. Scale bar, 10 μm. (D) In a PC12 cell line stably expressing trkB.FL (PC12-trkB+), neurite outgrowth in response to 50 ng/ml BDNF was significantly reduced in AdtrkB.t1ha-gfp-infected cells (p < 0.001, Student's t test) compared with AdlacZ-gfp-infected and uninfected cells, which were not significantly different. (E) No significant differences in neurite outgrowth were observed in infected and uninfected PC12-trkB+ cells treated with 50 ng/ml NGF. (F) In PC12 cells expressing TrkA, neurite outgrowth in response to 50 ng/ml NGF was significantly reduced in Adt-trkAha-gfp-infected cells (p < 0.001, Student's t test) compared with AdlacZ-gfp-infected and -uninfected cells, which were not significantly different. Bars indicate mean ± SEM. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 4 Transgene Expression and Lack of Inflammation following Adenovirus Infection of Mouse Sternomastoid Muscle Shown are sternomastoid muscle cross sections taken through the region containing neuromuscular junctions 1 month after infection on P2 with AdtrkB.t1ha-gfp (A–C) or Adt-trkAha-gfp (D–F). GFP fluorescence (A and D) and anti-HA staining (B and E) reveal transgene localization in the membrane of GFP+ muscle fibers. Overlay (C and F) shows that both transgenes are expressed in muscle fibers with high fidelity. In (G) and (H), no evidence of inflammation or infiltration of mononucleated cells, evidence of immune system involvement, is observed in H and E–stained cross sections of muscle 2 weeks after AdtrkB.t1ha-gfp infection at P2 (G) or 1 month after infection of adult SCID mice (H). Similar observations were made after infection with Adt-trkA-gfp and AdlacZ-gfp (data not shown). In (I), no evidence of myopathy was observed in muscles from trkB+/− mice. Scale bar, 40 μm. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 5 In Vivo Observation of GFP+ Muscle Fibers and Subsequent Analysis by Immunostaining and Confocal Microscopy Two to four weeks after AdlacZ-gfp infection, the sternomastoid muscle in living mice was exposed and imaged. (A) 4-Di-2-Asp-stained motor nerve terminals (yellow green) were visible on GFP+ muscle fibers (green, two fibers). (B) RαBTX-stained AChRs were also imaged; red patches are out-of-focus junctions. (C) After removal and fixation, the sternomastoid muscle was immunostained, using anti-neurofilament and anti-SV2 antigen antibodies, and confocal microscopy was used to visualize nerve terminals. (D) The same junctions were relocated based on the unique pattern of AChR-rich regions. Scale bar, 40 μm. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 6 Disassembly of Postsynaptic AChR Regions at Neuromuscular Junctions on AdtrkB.t1ha-gfp-Infected Neonatal Muscle Fibers (A–C) Immunostained nerve terminals ([A], green) and RαBTX-stained AChRs ([B], red), and the alignment of pre- and postsynaptic specializations ([C], overlay) at neuromuscular junctions on GFP+ muscle fibers from sternomastoid muscles infected with AdlacZ-gfp at P2. Junction area and pre- and postsynaptic alignment are similar to those observed in age-matched uninfected muscles. (D–L) Neuromuscular junctions on GFP+ muscle fibers from muscles infected with AdtrkB.t1ha-gfp at P2. (D–F) In ∼85% of junctions on GFP+ muscle fibers, the postsynaptic membrane contained many small, punctate AChR regions (E), which in many cases were completely occupied by motor nerve terminals ([D], overlay in [F]). (G–I) In ∼50% of these junctions, regions of high and low receptor density were observed. Faint AChR regions are a hallmark of synaptic sites in the process of being lost (cf. Balice-Gordon and Lichtman 1993); one faintly stained region of AChRs is indicated with an asterisk, although several are present. (J–L) In ∼30% of junctions, no motor nerve terminal staining was detected over small, punctate, disrupted AChR regions. The diffuse green staining in (J) is due to residual GFP plus nonspecific staining due to the secondary antibody, commonly seen in whole-mount preparations. (M–O) Motor nerve terminals (M) and AChRs (N), and the alignment of pre- and postsynaptic specializations ([O], overlay) at neuromuscular junctions on GFP+ muscle fibers from sternomastoid muscles infected with Adt-trkA-gfp at P2. Junction area and pre- and postsynaptic alignment are similar to those observed in uninfected muscles. Scale bar, 20 μm. (P) Histogram of the number of discrete AChR regions per junction from uninfected control sternomastoid muscle (upper) and AdlacZ-gfp- (upper middle), AdtrkB.t1ha-gfp- (lower middle), or Adt-trkA-gfp- (lower) infected muscles. The distribution from AdtrkB.t1ha-gfp-infected muscle fibers is significantly different from control or muscle fibers infected with other adenoviruses (p < 0.005, Komolgorov-Smirnoff test). Histograms from control and muscle fibers infected with other adenoviruses are not significantly different. The number of discrete AChR regions counted in the junction in (B) (left to right), 12, 6, and 7; in (E), 23; in (H), 19; in the three junctions shown en face in (K), >35, >35, and 14; and in (N), 3 and 4. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 7 Disassembly of Postsynaptic AChR Regions at Neuromuscular Junctions on AdtrkB.t1ha-gfp-Infected Adult Muscle Fibers (A–C) Anti-S-100 immunostaining of terminal and myelinating Schwann cells (A), immunostained nerve terminals (B), and RαBTX-stained AChRs (C) at neuromuscular junctions on GFP+ muscle fibers from adult SCID mouse sternomastoid muscle infected with AdlacZ-gfp 2 weeks previously. The size and alignment of pre- and postsynaptic specializations are similar to those seen in age-matched uninfected muscles. (D–I) Neuromuscular junctions on GFP+ muscle fibers infected with AdtrkB.t1ha-gfp 2 weeks previously. (D–F) In about half of the junctions on GFP+ fibers, Schwann cells are present (D), but motor nerve terminals (E) only partially occupy punctate and disrupted postsynaptic AChR regions (F) that contain faint AChR regions (one of several indicated with an asterisk). (G–I) In about half of the junctions on GFP+ fibers, Schwann cells (G) and motor nerve terminals (H) are present over punctate postsynaptic AChR regions (I) that contain faint AChR regions (one of several indicated with an asterisk). (J–L) Schwann cells (J), motor nerve terminals (K), and AChRs (L) appear normal at neuromuscular junctions on GFP+ muscle fibers infected with Adt-trkAha-gfp 2 weeks previously. Junction area and pre- and postsynaptic alignment are similar to those observed in age-matched uninfected muscles. Scale bar, 20 μm. (M) Histogram of the number of discrete AChR regions per junction from AdlacZ-gfp- (upper), AdtrkB.t1ha-gfp- (middle), and Adt-trkA-gfp- (lower) infected muscles. The distribution from uninfected control mice is shown in Figure 8J. The distribution from AdtrkB.t1ha-gfp-infected muscle fibers is significantly different from control muscle fibers or muscle fibers infected with other adenoviruses (p < 0.005, Komolgorov-Smirnoff test). Histograms from control muscle fibers and muscle fibers infected with other adenoviruses are not significantly different. The number of discrete AChR regions counted in the junction in (C) (left to right), 8, 5, and 5; in (F), 15; in (I), 23; and in (L), 8 and 7. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 8 Neuromuscular Junctions in trkB+/− Mice Have Numerous Punctate Postsynaptic AChR Regions (A–F) In neuromuscular junctions from the sternomastoid muscle of trkB+/− mice, terminal Schwann cells (A and D) and motor nerve terminals (B and E) are present over postsynaptic AChR regions (C) that contain numerous punctate AChR regions (C and F). (G–I) Terminal Schwann cells (G), motor nerve terminals (H), and postsynaptic AChR regions (I) from age- and sex-matched wild-type mice. The number of discrete AChR regions counted in the junction in (C), 8; in (F), 48; and in (I), 26. Scale bar, 10 μm. (J) Histogram of the number of discrete AChR regions per junction in trkB+/− mice (black bars) is significantly different from that from age- and sex-matched trkB+/+ mice (white bars; p < 0.001, Komolgorov-Smirnoff test). Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)

Figure 9 Disassembly of Agrin-Induced AChR Clusters on Myotubes Overexpressing TrkB.t1 (A) Three days of agrin treatment results in the formation of large AChR clusters ≥4 μm in length, visualized by RαBTX staining (red; three clusters on edge are present). Inset shows a large, contiguous en face AChR cluster. (B) In AdlacZ-gfp-infected myotubes, large AChR clusters (red; one on edge cluster is present), similar to those observed in uninfected myotubes, are present. (C) In AdtrkB.t1ha-gfp-infected myotubes, AChR clusters consisted of aggregations of many small, punctate regions, as opposed to the large, contiguous clusters seen in uninfected control myotubes (inset in [A]) or in AdlacZ-gfp-infected myotubes. Scale bar, 10 μm. (D) AdtrkB.t1ha-gfp-infected myotubes have significantly fewer AChR clusters ≥4 μm in length compared with uninfected or AdlacZ-gfp-infected myotubes (p < 0.001, Student's t test). Because agrin-induced clusters were present prior to infection, these results suggest that overexpression of trkB.t1 induces the disruption of existing agrin-induced AChR clusters. Bars indicate mean ± SEM. Neuron 1999 24, 567-583DOI: (10.1016/S0896-6273(00)81113-7)